Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2013 Oct 17;39(4):631-2.
doi: 10.1016/j.immuni.2013.10.002.

A "big data" view of the tumor "immunome"

Nicholas P Restifo  1
Affiliations
Comment

A "big data" view of the tumor "immunome"

Nicholas P Restifo. Immunity. .

Abstract

Tumors are complex masses containing not just neoplastic cells but also stromal cells, neovasculature, and a gamut of immune cells. In this issue, Bindea et al. (2013) identify a surprising new "immune landscape" associated with prolonged disease-free survival.

PubMed Disclaimer

Figures

Figure
Figure
Immune cells in tumor. Tumors masses are complex mixtures of cells that contain stromal cells, vasculature and a wide array of immune cells. Unsupervised correlation matrix of intra-tumor ‘immunome’ reveals that of the 28 cell types that were specifically analyzed, the strongest correlations with increased disease-free survival were with CTL, Tfh and B cells (shown in bold), which furthermore were correlated with each other.
See this image and copyright information in PMC

Comment on

References

    1. Bindea Cite, et al. Immunity, Present Issue.
    1. Fridman WH, Pages F, Sautes-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nature reviews. Cancer. 2012;12:298–306. - PubMed
    1. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313:1960–1964. - PubMed
    1. Hinrichs CS, Spolski R, Paulos CM, Gattinoni L, Kerstann KW, Palmer DC, Klebanoff CA, Rosenberg SA, Leonard WJ, Restifo NP. IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy. Blood. 2008;111:5326–5333. - PMC - PubMed
    1. Khong HT, Restifo NP. Natural selection of tumor variants in the generation of "tumor escape" phenotypes. Nature immunology. 2002;3:999–1005. - PMC - PubMed